Genprex provides clinical study updates for its Acclaim 1 and 3 trials
PremiumThe FlyGenprex provides clinical study updates for its Acclaim 1 and 3 trials
1M ago
Genprex granted patent in Singapore for Reqorsa gene therapy
Premium
The Fly
Genprex granted patent in Singapore for Reqorsa gene therapy
1M ago
Genprex price target lowered to $7.50 from $8 at Alliance Global Partners
Premium
The Fly
Genprex price target lowered to $7.50 from $8 at Alliance Global Partners
1M ago
Genprex CEO Rodney Varner passes away, CFO Ryan Confer succeeds
PremiumThe FlyGenprex CEO Rodney Varner passes away, CFO Ryan Confer succeeds
4M ago
Genprex collaborators report ‘positive’ data on Reqorsa, NPRL2 gene therapy
Premium
The Fly
Genprex collaborators report ‘positive’ data on Reqorsa, NPRL2 gene therapy
5M ago
Genprex expands clinical trial sites for study of Reqorsa in lung cancer
Premium
The Fly
Genprex expands clinical trial sites for study of Reqorsa in lung cancer
6M ago
Genprex receives Notice of Patent Grant for Korean patent
PremiumThe FlyGenprex receives Notice of Patent Grant for Korean patent
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
8M ago
Genprex expands nonclinical programs to study TUSC2
Premium
The Fly
Genprex expands nonclinical programs to study TUSC2
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100